Blossom Achieves Milestone with First International Export of Medical Cannabis to Spain

Blossom, a leading contract manufacturer in the medical cannabis industry, is thrilled to announce its first international export of medical cannabis products to Spain. This pivotal move marks Blossom's entry into the European market and signifies an expansion of its contract manufacturing capabilities on a global scale.

Broadening the Global Footprint With this successful export, Blossom solidifies its position as a global player in the medical cannabis sector. "This first international export to Spain is a monumental achievement for Blossom," said Blossom. "It highlights our capacity to meet international standards and regulatory requirements, paving the way for further expansion in the European market and beyond."

Regulatory Compliance and Quality Assurance Blossom's exported products have met all stringent quality and regulatory criteria set by both the Spanish Medicines Agency and Infarmed, ensuring full compliance with international standards. "Our commitment to quality and safety is unwavering, and we are proud that our products meet the high expectations of international regulators," added Oskar Fletcher, CEO of Blossom.

A Landmark Moment for the Company "Breaking into the European market has been a strategic goal for Blossom, and we couldn’t be more pleased to have achieved it," said Oskar Fletcher, CEO of Blossom. "We believe this is just the beginning, and we are excited to offer our specialised contract manufacturing services to a wider global clientele."

About Blossom Established in 2019, Blossom is a premier contract manufacturer specialising in the medical cannabis sector. With a focus on turnkey solutions, Blossom provides a comprehensive range of services for businesses interested in creating medical cannabis products. A commitment to quality, regulatory compliance, and client satisfaction has made Blossom a trusted name in cannabis contract manufacturing.

Future Aspirations As Blossom continues to expand its international reach, the company is looking to forge new partnerships and explore emerging markets, further solidifying its reputation as a leading contract manufacturer in the global medical cannabis industry.